CClinicalTrials.gg
TerminatedNCT02992054KODROUpdated Dec 14, 2016

An Innovative Occupational Program Using New Technologies (KODRO) Life of Nursing

An observational study in Home Residents, sponsored by University Hospital, Montpellier. Terminated. Open to participants aged 65 Months to 100 Years. Per ClinicalTrials.gov, last updated 2016-12-14.

Sponsored by University Hospital, Montpellier · Observational

Why this study was terminated
The number of patients were enough for statistic treatment
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
239
Ages
65 Months to 100 Years
Sex
All
01

Study summary

Randomized controlled trial for assessing the effects resulting from an innovative occupational program using new technologies (KODRO) on nursing home residents' quality of life

Context : improving quality of life (QOL) for the nursing homes residents (NHR) is a national priority (2010 report from French ANESM).

Read the detailed description

KODRO stimulation program makes available stimulating activities through the use of a tactile tablet computer. These tablets are linked to an internet-based service platform The project main objective is to demonstrate by way of a randomized controlled trial the significance of the improvement of residents' QOL achieved by 2 one-hour KODRO sessions per week during 6 months (KODRO nursing homes) when compared with the usual stimulation activity program (nursing homes "controls") (difference for the QOL-AD score > 2 points).At last, the objective of the study is also observational, i.e. to determine the quality of life of NHR at baseline, in its differents aspects.Subjects \& methods Analysis will be conducted to compare quantitative parameters at the beginning of the trial to verify the comparability of the two groups and of the mean average change between parameters measured at baseline, 3 months, and 6 months in both groups.

02

Conditions studied

  • Home Residents
03

In context

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Months to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Nursing home residents

Inclusion criteria

  • Nursing home residents

Exclusion criteria

Exclusion Criteria:

  • Not able to participate in the ocupational therapy using KODRO (Demential end of life ...)
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
239 participants (actual)
Patient registry
No

Groups and cohorts

  • Stimulating activities with the use of tactile tablet computer

    Stimulating activities through the use of a tactile tablet computer. These tablets are linked to an internet-based service platform and offer a very easy and intuitive interaction for the user, even when this person is suffering from a moderate cognitive and/or physical impairment.

    Other: stimulating activities

  • Stimulating activities with usual stimulation activity program

    No Stimulating activities through the use of a tactile tablet computer

Interventions

  • Otherstimulating activities
06

What researchers measure

Primary outcomes

  1. Quality of life: QOL-AD score: questionnaire

    Time frame: 6 months

Secondary outcomes

  1. Different aspects of QOL score: questionnaire

    Measurement of apathy * depression * anxiety * autonomy * self-esteem * overall well-being * behavioral problems * psychotropic medication use

    Time frame: 6 Months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 14, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02992054
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Dec 14, 2016
Start date
Dec 2010
Primary completion
Jan 2014
Completion
Jun 2014
Last update
Dec 14, 2016

Study contacts

Hubert BLAIN, MD, PHD
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion